Corporate
Profile

Failed to register as Favorite Page

Failed to cancel as Favorite Page

This page is already registered as a Favorite Page

You can't add your company to your favorites.

Latest update： 23/05/2018 10:44:52

NRL Pharma Co., Ltd.

We are a venture company, but we are a leader in Lactoferrin (LF) supplement business in Japan. Lactoferrin is a multi-functional protein and it has been widely used as a supplement in products such as infant formula and has a variety of health-care applications.

We have patents on enteric formulation of LF and on the method of improvement of lipid metabolism in Japan.   Sales of our patents licensed partner has been growing very rapidly reaching to about 100 million dollars due to an apparent clinical efficacy.

Inquiry

Sales Pitch

Enteric Lactoferrin supplement

Other presentation

[Company strength]
We are a venture company that focuses on the multifunctional protein "Lactoferrin", and we have a wide range of lactoferrin-related lines of business. We operate our lactoferrin business dynamically by devising, designing, and developing appropriate shapes and intake methods for multifunctional lactoferrin, considering each individual functionality.

[Business description]
We develop, manufacture, and sell health foods and food ingredients that contain lactoferrin (LF) as an active ingredient, which is a protein prevalent in milk. We are involved in R&D of new ascochlorin derivatives as drugs for the treatment of metabolic syndrome and malignant tumors. We are also pursuing R&D on the fusion of LF with the human antibody Fc region as a new medicine.

[Industry]
Drug and lactoferrin supplement development

[Representative's message]
Our business mostly deals with enteric coated lactoferrin pills. The effects of lactoferrin in reducing visceral fat have already been recognized in Japan, and many people are taking these pills. We hope to introduce this product to overseas markets. We look forward to inquiries from domestic Japanese and overseas companies that are interested in enteric lactoferrin.

[Company structure for market development/overseas expansion]
Our company is expanding partnerships in Japan as well as overseas, with a focus on Southeast Asia. Our target is future market growth and secure profits. We plan to make the most of the new system in the domestic Japanese market for foods with indications of functionality (enforced in April 2015) in expanding the lactoferrin market.

[Awards and media coverage]
[Awards]
Commendation for excellent utilization of industrial property rights (2010); commendation for excellent patent utilization, from the Minister of Economy, Trade and Industry; Japan Institute for Promoting Invention and Innovation, Kanto Region Invention competition, Invention Encouragement Award, for patents on lactoferrin compound (2010).

[Media]
Japan Patent Office, “Casebook on the Excellent Utilization of Intellectual Property Rights in the Private Sector” (2014).

[Intellectual property]
We possess seven patents on manufacturing methods, ten on applications, and seven on materials.

This company is recommended by the following support organizations.